Key Takeaways
- • Longfellow Real Estate Partners closed a $500 million inaugural life science real estate investment fund, marking the firm's entry into the sector with a debut vehicle.
- • The fund will target acquisition, development, and operation of life science and technology real estate assets across the United States.
- • Longfellow is actively developing a pair of office buildings in Durham, North Carolina, demonstrating early deployment of capital in the Research Triangle region.
- • The fund reflects growing institutional appetite for real estate dedicated to innovation and knowledge industries, positioning Longfellow among specialized operators in the life science property space.
Summary
Longfellow Real Estate Partners announced the closing of its $500 million inaugural life science real estate investment fund on July 10, 2018. The fund represents the firm's strategic entry into the specialized real estate sector focused on life science and technology properties. This debut vehicle is positioned to acquire, develop, and operate properties serving the innovation and knowledge industries across the United States.
The firm has already begun deploying capital, with a development pipeline that includes a pair of office buildings in Durham, North Carolina. The Durham projects underscore Longfellow's focus on established innovation hubs, particularly the Research Triangle region, which has emerged as a significant center for life science and biotechnology activity. By concentrating on purpose-built and specialized real estate for these sectors, Longfellow is targeting assets that benefit from structural tailwinds driven by growth in life science research, development, and commercialization activities.
The fund's closing reflects broader market recognition that life science real estate—including laboratory, office, and mixed-use properties designed for scientific and biotech tenants—represents a distinct and attractive real estate category. Jamie Peschel, Managing Partner of Longfellow Real Estate Partners, leads the firm's strategy in this space. The $500 million fund size positions Longfellow as a focused operator in a sector increasingly attracting institutional capital from major real estate investors and specialty funds.
The firm has already begun deploying capital, with a development pipeline that includes a pair of office buildings in Durham, North Carolina. The Durham projects underscore Longfellow's focus on established innovation hubs, particularly the Research Triangle region, which has emerged as a significant center for life science and biotechnology activity. By concentrating on purpose-built and specialized real estate for these sectors, Longfellow is targeting assets that benefit from structural tailwinds driven by growth in life science research, development, and commercialization activities.
The fund's closing reflects broader market recognition that life science real estate—including laboratory, office, and mixed-use properties designed for scientific and biotech tenants—represents a distinct and attractive real estate category. Jamie Peschel, Managing Partner of Longfellow Real Estate Partners, leads the firm's strategy in this space. The $500 million fund size positions Longfellow as a focused operator in a sector increasingly attracting institutional capital from major real estate investors and specialty funds.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.